Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin

被引：5
|
作者：
Matthews, Annette M.
Fireman, Marian
Zucker, Betsy
Sobel, Michelle
Hauser, Peter
机构：
[1] Portland VA Med Ctr, NW Hepatitis Resource Ctr C, JENS Lab, Gastroenterol Sect, Portland, OR 97202 USA
[2] Portland VA Med Ctr, Behav Hlth & Clin Neurosci Div, Portland, OR 97202 USA
[3] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97202 USA
[4] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97202 USA
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 2006年 / 163卷 / 08期
关键词：
D O I：
10.1176/appi.ajp.163.8.1342
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：1342 / 1347
页数：6
相关论文
共 50 条
  • [41] Delayed sustained virologic response after treatment of hepatitis C with pegylated interferon and ribavirin
    Yarze, Joseph C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S273 - S273
  • [42] Autoimmune Hepatitis Triggered by Treatment With Pegylated Interferon alpha-2a and Ribavirin for Chronic Hepatitis C
    Rathi, Chetan
    Pipaliya, Nirav
    Choksi, Dhaval
    Parikh, Pathik
    Ingle, Meghraj
    Sawant, Prabha
    ACG CASE REPORTS JOURNAL, 2015, 2 (04): : 247 - 249
  • [43] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Aizawa, Nobuhiro
    Enomoto, Hirayuki
    Takashima, Tomoyuki
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Imanishi, Hiroyasu
    Iijima, Hiroko
    Nishiguchi, Shuhei
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 1253 - 1263
  • [44] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [45] Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population
    Espinosa, Mario
    Hernandez, Jesus
    Dolores Arenas, Maria
    Carnicer, Fernando
    Caramelo, Carlos
    Fabrizi, Fabrizio
    KIDNEY & BLOOD PRESSURE RESEARCH, 2015, 40 (03): : 258 - 265
  • [46] Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Garib, Junia Rios
    Garcia, Guilherme Freire
    Teixeira, Rosangela
    Lima e Silva, Francisco das Chagas
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (08) : 625 - 631
  • [47] Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C
    Pattullo, Venessa
    Heathcote, E. Jenny
    Wong, David K. H.
    HEPATOLOGY INTERNATIONAL, 2010, 4 (04) : 723 - 731
  • [48] Using pegylated interferon and ribavirin to treat patients with chronic hepatitis C
    Ward, RP
    Kugelmas, M
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (04) : 655 - 662
  • [49] Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin
    Overbeck, Kathrin
    Genne, Daniel
    Golay, Alain
    Negro, Francesco
    JOURNAL OF HEPATOLOGY, 2008, 49 (02) : 295 - 298
  • [50] Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
    Nobuhiro Aizawa
    Hirayuki Enomoto
    Tomoyuki Takashima
    Yoshiyuki Sakai
    Kazunari Iwata
    Naoto Ikeda
    Hironori Tanaka
    Yoshinori Iwata
    Masaki Saito
    Hiroyasu Imanishi
    Hiroko Iijima
    Shuhei Nishiguchi
    Journal of Gastroenterology, 2014, 49 : 1253 - 1263
12345